Goldman Sachs’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Buy |
1,283,123
+605,961
| +89% | +$10.3M | ﹤0.01% | 1715 |
|
|
2025
Q1 | $13.2M | Sell |
677,162
-42,702
| -6% | -$834K | ﹤0.01% | 2016 |
|
|
2024
Q4 | $17.9M | Buy |
719,864
+39,016
| +6% | +$968K | ﹤0.01% | 1866 |
|
|
2024
Q3 | $16.7M | Sell |
680,848
-103,715
| -13% | -$2.54M | ﹤0.01% | 1867 |
|
|
2024
Q2 | $18.4M | Buy |
784,563
+232,351
| +42% | +$5.44M | ﹤0.01% | 1649 |
|
|
2024
Q1 | $18.2M | Buy |
552,212
+68,062
| +14% | +$2.25M | ﹤0.01% | 1617 |
|
|
2023
Q4 | $13.2M | Buy |
484,150
+22,433
| +5% | +$611K | ﹤0.01% | 1865 |
|
|
2023
Q3 | $11.1M | Sell |
461,717
-264,308
| -36% | -$6.36M | ﹤0.01% | 1912 |
|
|
2023
Q2 | $23.2M | Buy |
726,025
+67,767
| +10% | +$2.16M | 0.01% | 1442 |
|
|
2023
Q1 | $20.2M | Sell |
658,258
-360,134
| -35% | -$11M | ﹤0.01% | 1520 |
|
|
2022
Q4 | $39.8M | Sell |
1,018,392
-33,284
| -3% | -$1.3M | 0.01% | 1118 |
|
|
2022
Q3 | $50.1M | Buy |
1,051,676
+97,749
| +10% | +$4.66M | 0.01% | 972 |
|
|
2022
Q2 | $36.9M | Buy |
953,927
+124,680
| +15% | +$4.83M | 0.01% | 1161 |
|
|
2022
Q1 | $47.5M | Sell |
829,247
-144,771
| -15% | -$8.3M | 0.01% | 1119 |
|
|
2021
Q4 | $77.6M | Sell |
974,018
-70,064
| -7% | -$5.58M | 0.02% | 825 |
|
|
2021
Q3 | $90.8M | Buy |
1,044,082
+396,038
| +61% | +$34.5M | 0.02% | 704 |
|
|
2021
Q2 | $83.4M | Sell |
648,044
-86,173
| -12% | -$11.1M | 0.02% | 737 |
|
|
2021
Q1 | $58.8M | Sell |
734,217
-106,976
| -13% | -$8.56M | 0.01% | 923 |
|
|
2020
Q4 | $68.7M | Buy |
841,193
+529,904
| +170% | +$43.3M | 0.02% | 746 |
|
|
2020
Q3 | $7.66M | Sell |
311,289
-3,248
| -1% | -$80K | ﹤0.01% | 2124 |
|
|
2020
Q2 | $8.81M | Sell |
314,537
-48,421
| -13% | -$1.36M | ﹤0.01% | 2021 |
|
|
2020
Q1 | $6.53M | Buy |
+362,958
| New | +$6.53M | ﹤0.01% | 2076 |
|